drugset
drugset / Trial / NCT05957640

Yttrium-90 Carbon Microspheres in Patients With Unresectable Hepatocellular Carcinoma

NCT05957640 ↗

Phase 1 Unknown 40 enrolled Zhongda Hospital
NaSingle-groupOpen-labelTreatment

Summary

To evaluate the efficacy and safety of yttrium-90 carbon microspheres in patients with unresectable hepatocellular carcinoma

Timeline

Start
2023-05-05
Primary completion
2025-05-31
Completion
2025-05-31

Drugs

EvaluationDrugModalityDoseRoute
Subject yttrium-90 carbon microspheres Unknown — Other

Indications

hepatocellular carcinoma